U.S. Metals and Mining Stock News

The Morning Bull - US Market Morning Update Tuesday, Mar, 17 2026 E-mini S&P 500 futures are pointing higher this morning, up about 0.4%, as investors juggle mixed US factory data and rising pressure from the bond market. The NY Empire State Manufacturing Index sits at -0.2 in March, which means activity in New York factories has essentially stalled, a concern for jobs and overtime pay in industrial regions. At the same time, the 10 year US Treasury yield is holding near 4.24%, keeping...

Navitas Semiconductor unveiled a GaNFast powered 800 V to 6 V DC-DC power delivery board for AI data centers. The new architecture removes the traditional 48 V intermediate bus and is tailored for advanced NVIDIA AI infrastructure. The solution is being showcased at NVIDIA GTC 2026 and APEC 2026, highlighting real world validation with major industry partners. For investors watching NasdaqGM:NVTS, this announcement comes with the stock at $10.49, alongside a 25.2% return over the past week...

In recent days, Transense Technologies plc announced it had secured a £2.99 million DriveSense contract, led by Cummins and part-funded by the UK Government, to develop next-generation smart electric drive systems for heavy-duty zero-emission vehicles, while Cummins also expanded its use of Laser Photonics’ CleanTech laser technology in engine maintenance. Together with Cummins’ data center-driven Power Systems strength and ongoing legal and competitive pressures, these developments...

If you are wondering whether Wendy's at around US$7.04 is a bargain or a value trap, this article will help you weigh what the current share price might be implying. The stock has faced heavy pressure, with returns of 3.2% over 7 days, 5.9% over 30 days, 13.8% year to date, 51.1% over the past year, and 60.3% and 57.6% over 3 and 5 years respectively. Recent attention on Wendy's has focused on broader questions around its brand position, store footprint and capital allocation. All of these...

Stock performance context for CorMedix Without a specific news catalyst driving fresh headlines, CorMedix (CRMD) continues to draw attention as investors weigh its recent share performance in relation to its role in developing therapies for life threatening conditions. The stock last closed at US$6.54, with returns showing mixed momentum. It recorded a 1.4% gain over the past day, alongside a slight decline over the past week. See our latest analysis for CorMedix. Recent trading tells a mixed...

Board member Raymond A. Link recently sold nearly 25% of his nLIGHT (NasdaqGS:LASR) holdings. The sale came shortly after the company reported record revenue tied to defense focused products. The transaction followed a period of strong momentum in nLIGHT's aerospace and defense laser business. nLIGHT, listed on NasdaqGS:LASR, develops high power semiconductor and fiber lasers used in industrial, aerospace and defense applications. The business has been gaining attention for its defense...

NeoGenomics (NEO) has drawn attention after its share price closed at $8.24, with recent returns showing pressure over the past month and past 3 months, prompting investors to reassess the cancer testing specialist. See our latest analysis for NeoGenomics. The recent 1 day share price return of 4.57% comes after a 30 day share price decline of 27.59% and a 1 year total shareholder return of 16.26% in the red. This indicates that pressure has been building for some time rather than momentum...

Veracyte, Inc. recently appointed Kevin Haas, Ph.D., as its first Chief Development and Technology Officer, tasking him with overseeing end-to-end product development across diagnostic assays, software, bioinformatics and program management to support its expanding global portfolio of laboratory-developed tests and in vitro diagnostic products. This new role, filled by a leader with deep experience in automated lab technology, AI and genomics platforms, underscores Veracyte’s intent to more...

What Fidelis Insurance Holdings’ completed buyback means for shareholders Fidelis Insurance Holdings (FIHL) has just wrapped up a sizeable buyback, repurchasing 18,823,327 shares for US$351.4 million, equal to 18.24% of its share base under a program launched in August 2025. From October 1, 2025 to March 3, 2026 alone, the company bought back 16,988,264 shares, or 16.49% of its stock, at a time when the shares most recently closed at US$18.95. See our latest analysis for Fidelis Insurance...

Pharvaris recently reported that a company-sponsored real-world, mixed methods study on patient experiences during acute hereditary angioedema (HAE) attacks and related clinical endpoints has been published in Clinical Reviews in Allergy & Immunology, supporting the use of several patient-reported outcome (PRO) tools in ongoing and future deucrictibant trials. The study’s finding that patients view even small early improvements, captured by the End of Progression™ endpoint, as meaningfully...

Extreme Networks (EXTR) shares are in focus after Cellhub, a healthcare technology aggregator and Primary Agent for T-Mobile, agreed to use the company’s AI-powered networking in its Hospitals Without Walls connectivity program. See our latest analysis for Extreme Networks. The recent Cellhub agreement comes as Extreme Networks trades at US$14.83, with a 7 day share price return of 5.70%, a 90 day share price return of 11.67%, and a 3 year total shareholder return of 17.70%. If you are...

Earlier this month, BANF announced a collaboration with Silicon Labs to integrate the ultra‑low‑power BG22 Bluetooth LE SoC and Secure Vault security into BANF’s new in‑tire, battery‑free sensor platform for autonomous and connected vehicles. By digitizing real‑time tire conditions with on‑tire data processing and wireless power transfer, the partnership turns tires into high‑value data sources for safety, fleet management, and future predictive services. We’ll now examine how embedding...

In its latest quarter, Viasat reported earnings per share that exceeded analyst expectations even as revenue came in slightly below forecasts, reflecting resilient performance across its global satellite communications services. An interesting angle is that this earnings strength coincided with a pre-planned insider share sale by the Chief Accounting Officer, underscoring how routine trading plans can intersect with periods of strong operating results. We’ll now explore how Viasat’s...

Voya Financial (VOYA) is back in focus after its latest quarterly update, where US$2.01b in revenue matched expectations but earnings per share fell short, and the stock has dropped 12.2% since the announcement. See our latest analysis for Voya Financial. Beyond the post results drop, Voya Financial’s share price has seen a 9.21% decline over 30 days and a 10.52% year to date share price return. Its 1 year total shareholder return of 2.98% and 5 year total shareholder return of 17.71% suggest...

Roper Technologies (ROP) is back in focus after Q4 2025 results slightly beat EPS expectations but missed on revenue, while management doubled down on AI expansion, disciplined acquisitions, and conservative 2026 guidance. See our latest analysis for Roper Technologies. The mixed Q4 report and conservative 2026 outlook come after a volatile stretch. A 9.58% 1 month share price return contrasts with a 20.64% 3 month share price decline and a 38.41% 1 year total shareholder return loss,...

Silvaco Group (SVCO) surprised the market with quarterly results that came in ahead of expectations, along with revenue guidance above earlier forecasts and cost cuts tracking better than management initially outlined. See our latest analysis for Silvaco Group. Silvaco Group’s recent earnings beat and upbeat guidance have been met with sharp share price momentum, with a 7 day share price return of 53.5% and a year to date share price return of 22%, even though the 1 year total shareholder...

TopBuild Corp. recently reported that fourth-quarter revenue rose 13.2%, driven largely by its acquisition program, including the SPI purchase completed last year. The company’s seven acquisitions in 2025 added nearly US$1.20 billion in sales and underpin its 2026 revenue outlook of US$5.93 billion to US$6.23 billion with adjusted EBITDA of US$1.01 billion to US$1.16 billion. We’ll now examine how this acquisition-fueled revenue growth and 2026 outlook could influence TopBuild’s existing...

Niu Technologies (NasdaqGM:NIU) closed out FY 2025 with fourth quarter revenue of C¥676.2 million and a basic EPS loss of C¥1.10, alongside trailing twelve month revenue of C¥4.3 billion and a basic EPS loss of C¥0.49. Over recent quarters the company has seen revenue range from C¥681.9 million to C¥1.7 billion, with quarterly basic EPS swinging between a loss of C¥0.49 and a profit of C¥1.02. This underscores how volatile earnings have been around a still unprofitable margin profile. See our...

Why Axalta Coating Systems (AXTA) Is Back Under Pressure Axalta Coating Systems (AXTA) has come under fresh scrutiny after underperforming in its latest quarter and guiding to a mid single digit revenue decline, alongside rising raw material costs and softer North American demand. See our latest analysis for Axalta Coating Systems. The Q4 2025 earnings miss and softer Q1 2026 outlook have been reflected in the share price, with a 30 day share price return showing an 18.17% decline and a 1...

Safety Insurance Group (SAFT) is in focus after reporting an improved combined ratio of 99% in 2024, a well covered dividend, and a 4.2% yield on its investment portfolio. See our latest analysis for Safety Insurance Group. The share price sits at $73.53 after a 1 day share price return of 0.40% and a 7 day share price return of 1.21%. However, the 30 day share price return of 7.31% and year to date share price return of 2.88% point to fading short term momentum. The 3 year total shareholder...

In March 2026, GRAIL, Inc. announced that CEO Bob Ragusa will retire on June 1, 2026, with President Josh Ofman, MD, MSHS, set to become CEO and join the Board, while Ragusa remains as a senior advisor through March 2027. This leadership transition places a long-time internal executive with deep clinical and health policy experience at the center of GRAIL’s next phase of development. Next, we’ll examine how Ofman’s planned move from president to CEO could reshape GRAIL’s investment narrative...

Townsquare Media (TSQ) FY 2025 Earnings Snapshot Townsquare Media (TSQ) has wrapped up FY 2025 with Q4 revenue of US$106.5 million and a basic EPS loss of US$0.32, while trailing twelve month figures show revenue at US$427.4 million and a basic EPS loss of US$0.71. Over recent quarters the company has seen revenue move from US$117.8 million in Q4 2024 to US$106.5 million in Q4 2025, with EPS shifting from a profit of US$1.59 to a loss of US$0.32. This sets up a story where revenue is...

Why Envista Holdings is on investors’ radar today Envista Holdings (NVST) is back in focus after recent trading, with the share price closing at $25.02 and short term returns mixed between a 1 day gain and a weaker past week. Over the past month the stock has recorded a 14% decline, while the past 3 months show a 14% total return, giving investors a compact snapshot of recent volatility and recovery. See our latest analysis for Envista Holdings. That recent 14.25% 3 month share price return...

Cytokinetics (NasdaqGS:CYTK) presented new clinical data on MYQORZO (aficamten) for obstructive hypertrophic cardiomyopathy at a major cardiology conference. The updates covered exercise capacity outcomes, effectiveness across patients with and without hypertension, and safety during treatment interruption and restart. The new analyses expand the clinical profile of MYQORZO, a recently approved oHCM therapy, and add detail on how the drug performs in real treatment scenarios. Cytokinetics...